COPENHAGEN, May 13 (Reuters) - The Danish medicines agency on Monday warned of a supply shortage for two separate doses of Novo Nordisk's hugely popular weight loss drug Wegovy due to increasing demand. (Reporting by Louise Breusch Rasmussen, editing by Terje Solsvik)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
985.1 DKK | -0.33% | +5.45% | +41.41% |
Jun. 10 | Dsm-firmenich sees boost as weight-loss drugs spur healthier choices | RE |
Jun. 10 | Argus Research Raises Novo Nordisk Price Target to $160 From $125, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.41% | 631B | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+17.79% | 249B | |
-2.00% | 216B | |
+11.09% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Denmark faces Wegovy shortage due to rising demand, medicines agency says